May 2 |
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
|
May 1 |
Altimmune to Participate at Two Upcoming Conferences
|
Apr 30 |
Peering Into Altimmune's Recent Short Interest
|
Apr 29 |
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Apr 25 |
Altimmune Statement on the Passing of Dr. Stephen Harrison
|
Apr 12 |
Buy Altimmune's Potential Market Disruption With Pemvidutide
|
Mar 27 |
Altimmune: Despite HepTcell Failure, Differentiation Of Obesity Drug In Place
|
Mar 27 |
Altimmune, Inc. (ALT) Q4 2023 Earnings Call Transcript
|
Mar 27 |
Altimmune falls after Q4 results; obesity drug data released
|
Mar 27 |
Altimmune GAAP EPS of -$0.54 misses by $0.16
|